Childcare Expansion for Military Families Act of 2021

Issues related to drug pricing reform -Changes to Public law 117-1769 Inflation Reduction Act -Awareness of implications to patients and research and development of Public law 117-1769 Inflation Reduction Act S. 113 Prescription Pricing for the People Act of 2023 S.127 Pharmacy Benefit Manager Transparency Act HR 830/ S 1375 HELP Copays Act HR 485 Protecting Health Care for All Patients Act HR 5378 Lower Costs, More Transparency Act R 2534 PROTECT 340B Act of 2023 HR 3561 the PATIENT Act S. 1542 DRUG Act S. 1967 PBM Act HR 3503 The NIH Clinical Trials Diversity Act Issues related to cardiovascular disease awareness and treatment Issues related to Federal Trade Commission FDA issues Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Biosimilars reimbursement issues, no specific bill Supply Chain Issues, no specific bill Issues related to 340B Issues related to pharmacy benefit managers Proposed rule: Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program HR 4818/ S. 2407 Treat and Reduce Obesity Act S. 2305 Biosimilar Red Tape Elimination Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act Issues related to PAHPA reauthorization Modernizing and Ensuring PBM Accountability Act (Finance Committee) S. 652 SAFE Step Act S 2474/ HR 5376 Share the Savings with Seniors Act S 2456 Protecting Seniors from High Drug Costs Act HR4881 To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program HR 3281 Protecting Patients Against PBM Abuses Act HR 4822 Health Care Price Transparency Act of 2023 S 1339 Pharmacy Benefit Manager Reform Act HR 2679 Pharmacy Benefits Manager Accountability Act HR 4507 Transparency in Coverage Act of 2023 HR 1352 Increasing Access to Biosimilars Act of 2023 HR 2880 Protecting Patients Against PBM Abuses Act Issues pertaining to the implementation of PL 97-414 "Orphan Drug Act," all provisions. HR 5539 Orphan Cures Act HR 5547 Maintaining Investments in New Innovation Act S 3558 BIOSECURE Act HR 7174 Ensuring Pathways to Innovative Cures (EPIC Act) S Res 566 Cholesterol Education Month 2024 HR 7635 340B PATIENTS Act of 2024 H.R. 5391 / S. 2764 The Protecting Patient Access to Cancer and Complex Therapies Act

Client expense: $3,330,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to drug pricing reform -Changes to Public law 117-1769 Inflation Reduction Act -Awareness of implications to patients and research and development of Public law 117-1769 Inflation Reduction Act S. 113 Prescription Pricing for the People Act of 2023 S.127 Pharmacy Benefit Manager Transparency Act HR 830/ S 1375 HELP Copays Act HR 485 Protecting Health Care for All Patients Act HR 1613 to amend title XIX of the Social Security Act to improve transparency and prevent the use of abusive spread pricing and related practices in the Medicaid program R 2534 PROTECT 340B Act of 2023 HR 3561 the PATIENT Act S. 1542 DRUG Act S. 1967 PBM Act HR 3503 The NIH Clinical Trials Diversity Act Proposed rule: Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program HR 4818/ S. 2407 Treat and Reduce Obesity Act S. 2305 Biosimilar Red Tape Elimination Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act Modernizing and Ensuring PBM Accountability Act (Finance Committee) S. 652 SAFE Step Act S 2474/ HR 5376 Share the Savings with Seniors Act S 2456 Protecting Seniors from High Drug Costs Act HR4881 To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program HR 3281 Protecting Patients Against PBM Abuses Act HR 4822 Health Care Price Transparency Act of 2023 S 1339 Pharmacy Benefit Manager Reform Act HR 2679 Pharmacy Benefits Manager Accountability Act HR 4507 Transparency in Coverage Act of 2023 HR 1352 Increasing Access to Biosimilars Act of 2023 HR 2880 Protecting Patients Against PBM Abuses Act Issues related to PAHPA reauthorization Issues related to cardiovascular disease awareness and treatment Issues related to Federal Trade Commission FDA issues Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Biosimilars reimbursement issues, no specific bill Supply Chain Issues, no specific bill Issues related to 340B Issues related to pharmacy benefit managers

Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation

Issues related to drug pricing reform -Changes to Public law 117-1769 Inflation Reduction Act -Awareness of implications to patients and research and development of Public law 117-1769 Inflation Reduction Act S. 113 Prescription Pricing for the People Act of 2023 S.127 Pharmacy Benefit Manager Transparency Act HR 830/ S 1375 HELP Copays Act HR 485 Protecting Health Care for All Patients Act HR 5378 Lower Costs, More Transparency Act R 2534 PROTECT 340B Act of 2023 HR 3561 the PATIENT Act S. 1542 DRUG Act S. 1967 PBM Act HR 3503 The NIH Clinical Trials Diversity Act Issues related to cardiovascular disease awareness and treatment Issues related to Federal Trade Commission FDA issues Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Biosimilars reimbursement issues, no specific bill Supply Chain Issues, no specific bill Issues related to 340B Issues related to pharmacy benefit managers Proposed rule: Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program HR 4818/ S. 2407 Treat and Reduce Obesity Act S. 2305 Biosimilar Red Tape Elimination Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act Issues related to PAHPA reauthorization Modernizing and Ensuring PBM Accountability Act (Finance Committee) S. 652 SAFE Step Act S 2474/ HR 5376 Share the Savings with Seniors Act S 2456 Protecting Seniors from High Drug Costs Act HR4881 To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program HR 3281 Protecting Patients Against PBM Abuses Act HR 4822 Health Care Price Transparency Act of 2023 S 1339 Pharmacy Benefit Manager Reform Act HR 2679 Pharmacy Benefits Manager Accountability Act HR 4507 Transparency in Coverage Act of 2023 HR 1352 Increasing Access to Biosimilars Act of 2023 HR 2880 Protecting Patients Against PBM Abuses Act Issues pertaining to the implementation of PL 97-414 "Orphan Drug Act," all provisions.

Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation

Issues related to drug pricing reform -Changes to Public law 117-1769 Inflation Reduction Act -Awareness of implications to patients and research and development of Public law 117-1769 Inflation Reduction Act S. 113 Prescription Pricing for the People Act of 2023 S.127 Pharmacy Benefit Manager Transparency Act HR 830/ S 1375 HELP Copays Act HR 485 Protecting Health Care for All Patients Act HR 1613 to amend title XIX of the Social Security Act to improve transparency and prevent the use of abusive spread pricing and related practices in the Medicaid program R 2534 PROTECT 340B Act of 2023 HR 3561 the PATIENT Act S. 1542 DRUG Act S. 1967 PBM Act HR 3503 The NIH Clinical Trials Diversity Act Proposed rule: Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program HR 4818/ S. 2407 Treat and Reduce Obesity Act S. 2305 Biosimilar Red Tape Elimination Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act Modernizing and Ensuring PBM Accountability Act (Finance Committee) S. 652 SAFE Step Act S 2474/ HR 5376 Share the Savings with Seniors Act S 2456 Protecting Seniors from High Drug Costs Act HR4881 To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program HR 3281 Protecting Patients Against PBM Abuses Act HR 4822 Health Care Price Transparency Act of 2023 S 1339 Pharmacy Benefit Manager Reform Act HR 2679 Pharmacy Benefits Manager Accountability Act HR 4507 Transparency in Coverage Act of 2023 HR 1352 Increasing Access to Biosimilars Act of 2023 HR 2880 Protecting Patients Against PBM Abuses Act Issues related to PAHPA reauthorization Issues related to cardiovascular disease awareness and treatment Issues related to Federal Trade Commission FDA issues Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Biosimilars reimbursement issues, no specific bill Supply Chain Issues, no specific bill Issues related to 340B Issues related to pharmacy benefit managers

Physician payment issues (MEI, E/M Budget Neutrality, APMs, MIPS) Prior authorization in Medicare Advantage; S.1512 - CONNECT for Health Act of 2021 Monitoring PBM legislation - S. 1967 and S. 1038

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to drug pricing reform -Changes to Public law 117-1769 Inflation Reduction Act -Awareness of implications to patients and research and development of Public law 117-1769 Inflation Reduction Act S. 113 Prescription Pricing for the People Act of 2023 S.127 Pharmacy Benefit Manager Transparency Act HR 830/ S 1375 HELP Copays Act HR 485 Protecting Health Care for All Patients Act HR 1613 to amend title XIX of the Social Security Act to improve transparency and prevent the use of abusive spread pricing and related practices in the Medicaid program HR 2534 PROTECT 340B Act of 2023 HR 3561 the PATIENT Act S. 1542 DRUG Act S. 1967 PBM Act Issues related to cardiovascular disease awareness and treatment Issues related to Federal Trade Commission FDA issues Issues related to clinical trial diversity Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Biosimilars reimbursement issues, no specific bill Supply Chain Issues, no specific bill Issues related to 340B Issues related to pharmacy benefit managers

Client expense: $1,950,000 · Firm income: Not reported

Issues related to drug pricing reform -Changes to Public law 117-1769 Inflation Reduction Act -Awareness of implications to patients and research and development of Public law 117-1769 Inflation Reduction Act S. 113 Prescription Pricing for the People Act of 2023 S.127 Pharmacy Benefit Manager Transparency Act HR 830/ S 1375 HELP Copays Act HR 485 Protecting Health Care for All Patients Act HR 1613 to amend title XIX of the Social Security Act to improve transparency and prevent the use of abusive spread pricing and related practices in the Medicaid program HR 2534 PROTECT 340B Act of 2023 HR 3561 the PATIENT Act S. 1542 DRUG Act S. 1967 PBM Act Issues related to cardiovascular disease awareness and treatment Issues related to Federal Trade Commission FDA issues Issues related to clinical trial diversity Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Biosimilars reimbursement issues, no specific bill Supply Chain Issues, no specific bill Issues related to 340B Issues related to pharmacy benefit managers

Client expense: $1,950,000 · Firm income: Not reported

Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits H.R.2666 -- Medicaid MVP for Patients Act S.652 / H.R.2630 -- Safe Step Act H.R.2679 -- Pharmacy Benefits Manager Accountability Act H.R.2691 - Transparent PRICE Act H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications Act H.R.3561 - Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.4011 - Timely Access to Clinical Treatment Act S.1038 / H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacist Services Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S. 1375 / H.R.830 - Help Ensure Lower Patient (HELP) Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.3799 - CHOICE Arrangement Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act H.R.3284 - Providers and Payers COMPETE Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation Implementation of Center for Medicare and Medicaid Services Final Rule, Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Final Rule, CMS-4192-F, CMS-1744-F, provisions related to changes in Pharmacy Direct and Indirect Renumeration

Client expense: $3,402,542 · Firm income: Not reported

Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, pharmacy networks, and mail-service pharmacy S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act H.R.2679 - Pharmacy Benefits Manager Accountability Act H.R.2691 - Transparent PRICE Act H.R.3281 - Transparent PRICE Act S.1339 - Pharmacy Benefit Manager Reform Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3561 - Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.1038 / H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacist Services Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act H.R.3284 - Providers and Payers COMPETE Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation Implementation of Center for Medicare and Medicaid Services Final Rule, Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Final Rule, CMS-4192-F, CMS-1744-F, provisions related to changes in Pharmacy Direct and Indirect Renumeration

Client expense: $3,402,542 · Firm income: Not reported

Issues related to prescription drug coverage and pharmacy benefits Issues related to the prescription drug marketplace, patents, and competition Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act H.R.2666 - Medicaid MVP for Patients Act S.652 / H.R.2630 - Safe Step Act H.R.2679 - Pharmacy Benefits Manager Accountability Act H.R.2691 - Transparent PRICE Act H.R.3281 - Transparent PRICE Act S.1339 - Pharmacy Benefit Manager Reform Act S.1543 - A bill to require regulations concerning the disclosure of direct and indirect compensation from entities providing pharmacy benefit management services or third party administration services H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications Act H.R.3561 - Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act H.R.4011 - Timely Access to Clinical Treatment Act S.1038 / H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacist Services Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S. 1375 / H.R.830 - Help Ensure Lower Patient (HELP) Copays Act S.954 / H.R.1488 - Affordable Insulin Now Act H.R.1503 - Prescription Information Modernization Act H.R.1352 - Increasing Access to Biosimilars Act S.1374 - Patient Right to Shop Act H.R.3799 - CHOICE Arrangement Act S.142 - Preserve Access to Affordable Generics and Biosimilars Act S.148 - Stop STALLING Act S.150 - Affordable Prescriptions for Patients Act S.574 - Increasing Prescription Drug Competition Act S.775 - Increasing Transparency in Generic Drug Applications Act H.R.1790 - Biologics Competition Act S.1067 - Ensuring Timely Access to Generics Act S.1114 - Expanding Access to Low-Cost Generics Act S.1120 - Improved Access to Affordable Medications Act S.1128 - Ensuring Access to Generic Medications Act S.1522 - A bill to require the Secretary of Health and Human Services to conduct a study on the designation of biosimilar biological products as interchangeable S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act H.R.3284 - Providers and Payers COMPETE Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation Implementation of Center for Medicare and Medicaid Services Final Rule, Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Final Rule, CMS-4192-F, CMS-1744-F, provisions related to changes in Pharmacy Direct and Indirect Renumeration

H.R. 198: Drug Pricing Transparency and Accountability Act - Provisions related to the 340B Program H.R. 830/ S. 1375: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes H.R. 1790: Biologics Competition Act of 2023 - To direct the Secretary of Health and Human Services to evaluate the extent to which the substitution of interchangeable biological products is impacted by differences between the system for determining a biological product to be interchangeable and the system for assigning therapeutic equivalence ratings to drugs, and for other purposes H.R. 2500: Protecting Americans from Unsafe Drugs Act of 2023 H.R. 2679: Pharmacy Benefit Manager Accountability Act H.R. 2816: Pharmacy Benefit Manager Sunshine and Accountability Act H.R. 2940/S 1355 PASTEUR Act/Incentives to increase novel antibiotic medicines H.R. 2880: Protecting Patients Against PBM Abuses Act H.R. 3008: Drug Shortage Prevention Act of 2023 H.R. 3281: Transparent PRICE Act H.R. 3285: Fairness for Patient Medications Act H.R. 3290: To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program/Transparency Legislation H.R. 3433: Give Kids a Chance Act of 2023 H.R. 3561: Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or PATIENT Act of 2023 H.R. 3791: Improving DATA in Public Health Act H.R. 3793: Ensuring Access to Lifesaving Drugs Act of 2023 H.R. 3810: Drug Origin Transparency Act of 2023 H.R. 4390: Protect 340B Act - Provisions related to 340B Program (117th Congress) H.R. 5376: Inflation Reduction Act of 2022 (P.L. 117-169)/Implementation of $0 Vaccine co-pay; maximum fair price provisions H.R. 7032: Increasing Transparency in Generic Drug Applications Act of 2022 - This bill requires the Food and Drug Administration to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why) (117th Congress) H.R. 7653: Modern Authentication of Pharmaceuticals Act of 2022 (117th Congress) S. 6: Biosimilar Red Tape Elimination Act (117th Congress) S. 113: Prescription Pricing for the People Act of 2023 - Provisions related to PBMs S. 127: Pharmacy Benefit Manager Transparency Act of 2023 - Provisions related to PBMs S. 148: Stop STALLING Act - Provisions related to citizen petitions S. 315: Taxpayer Research And Contributions Knowledge Act of 2023 or TRACK Act of 2023 - To direct the Secretary of Health and Human Services and other Federal officials to compile into a searchable database information relating to Federal support for biomedical research and development, and for other purposes. S. 476: Maintaining Investments in New Innovation Act S. 775: Increasing Transparency in Generic Drug Applications Act S. 1128: Ensuring Access to Generic Medications Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 - Provisions related to drug pricing (117th Congress) S. 1967: Patients Before Middlemen (PBM Act) S. 1067: Ensuring Timely Access to Generics Act of 2023 S. 1114: Expanding Access to Low-Cost Generics Act 2023 S. 1214: RARE Act - To set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions S. 1264: SMART Prices Act - Provisions related to drug pricing reform S. 1339: Pharmacy Benefit Manager Reform Act - Provisions related to PBMs S. 1355: PASTEUR Act of 2023 - Provisions related to antimicrobial resistance policy issues S. 1375: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes S. 1542: Delinking Revenue from Unfair Gouging Act or DRUG Act - Provisions related to PBMs S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act or PREVENT Pandemics Act (117th Congress) Pharmacy Benefit Manager reform and policy issues Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA) Cancer Moonshot Initiative 21st Century Cures 2.0 Drug cost and pricing policy issues Principles for drug pricing reform Drug importation policy issues Accelerated approval policy issues FDA regulatory approval authority policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance (AMR) policy issues Mental health policy issues High deductible health plans/HSA policy issues Supply chain policy issues Real world evidence policy issues Clinical trial diversity policy issues Prescription drug abuse policy issues 340B drug discount program policy issues Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues COVID-19 policy issues Pandemic preparedness policy issues Defense Production Act policy issues Cybersecurity policy issues Anticounterfeiting policy issues Chronic Kidney Disease Improvement in Research and Treatment Act. H.R.2534 - PROTECT 340B Act of 2023 House Draft Language for PAHPA Reauthorization HR 3665 - Defending American Jobs and Investment Act Senate Draft Language for PAHPA Reauthorization Pandemic and All Hazards Preparedness Act reauthorization (discussion draft) Labor HHS appropriations (ongoing discussion) Under Taxed Profit Rule, Ways and Means Committee discussion Vaccine Injury Compensation Program reform discussion

HR475-TRICARE young adult;HR1302-Gold Star; HR1309-eating disorders; HR1767-languages; HR1836-Guard parity; S943-Parris Island; S781-paid leave; S894-Hire Vets; S156 TRICARE re-enroll; HR333/HR303/S344/HR1282-Concurrent Receipt; S781-Parental Leave; S943-Parris Island Protection; HR2146-Military Family Violence; HR2339- Military Hunger Prevention; HR2214-Final month pay; HR1491-Fair Debt Collection; HR2320- Parental Leave; HR2502- Gender Equity Pay; S1084- Military Spouse Licensing; S1147- Concurrent Receipts; S1572-Military Childcare; HR3102- TRICARE Protection; HR3121- Military Child Care; S1781- Military Nutrition; S1273-Military Spouse Retirement; HR3626- Guard and Reserve Pay Parity; HR3712- Dogs for disease detection; HR3368- Toxic Exposure; HR3512- TRICARE for Reserve; S1967-Childcare Expansion; S1970- Clean Water for Military; S1972- Tricare young adult; S1973-PFAS Toxic Exposure; HR4339- Toxic Exposure; HR4340- Toxic Exposure; HR4379- Burn Pits; S2161- 180day Rule (Skill retaining); HR4861- DoD School Funding; HR4700- Skillbridge Program; HR4702- Military Spouse Tax; HR5061- Mental Health, HR4031- 180 Rule (Retaining Skill); HR4241-PFAS Cleanup; HR4824- Mental Health; HR4882- Recreational Therapy; S2518- Toxic Exposure; S2555- PFAS Cleanup; HR5198 - Casualty Assistance; HR5379 - Pay during lapse in appropriation; HR5403 -PFAS; HR2195 - Protecting Reservist Employment; HR2196- Forced Arbitration; HR5402 - Vetting Privatize Housing; HR5752 - SCRA; HR5255 - Child Impact Aid; HR6227 - Military Children School Meal; HR7041 - Military Records; HR7526 - Credit Monitoring; HR7563- Active Duty Home Ownership; HR7564 - Building More Houses; HR7561 - BAH Restoration;

Client expense: $120,000 · Firm income: Not reported

HR475-TRICARE young adult;HR1302-Gold Star; HR1309-eating disorders; HR1767-languages; HR1836-Guard parity; S943-Parris Island; S781-paid leave; S894-Hire Vets; S156 TRICARE re-enroll; HR333/HR303/S344/HR1282-Concurrent Receipt; S781-Parental Leave; S943-Parris Island Protection; HR2146-Military Family Violence; HR2339- Military Hunger Prevention; HR2214-Final month pay; HR1491-Fair Debt Collection; HR2320- Parental Leave; HR2502- Gender Equity Pay; S1084- Military Spouse Licensing; S1147- Concurrent Receipts; S1572-Military Childcare; HR3102- TRICARE Protection; HR3121- Military Child Care; S1781- Military Nutrition; S1273-Military Spouse Retirement; HR3626- Guard and Reserve Pay Parity; HR3712- Dogs for disease detection; HR3368- Toxic Exposure; HR3512- TRICARE for Reserve; S1967-Childcare Expansion; S1970- Clean Water for Military; S1972- Tricare young adult; S1973-PFAS Toxic Exposure; HR4339- Toxic Exposure; HR4340- Toxic Exposure; HR4379- Burn Pits; S2161- 180day Rule (Skill retaining); HR4861- DoD School Funding; HR4700- Skillbridge Program; HR4702- Military Spouse Tax; HR5061- Mental Health, HR4031- 180 Rule (Retaining Skill); HR4241-PFAS Cleanup; HR4824- Mental Health; HR4882- Recreational Therapy; S2518- Toxic Exposure; S2555- PFAS Cleanup; HR5198 - Casualty Assistance; HR5379 - Pay during lapse in appropriation; HR5403 -PFAS; HR2195 - Protecting Reservist Employment; HR2196- Forced Arbitration; HR5402 - Vetting Privatize Housing; HR5752 - SCRA; HR5255 - Child Impact Aid; HR6227 - Military Children School Meal; HR7041 - Military Records; HR7526 - Credit Monitoring; HR7563- Active Duty Home Ownership; HR7564 - Building More Houses; HR7561 - BAH Restoration;

Client expense: $120,000 · Firm income: Not reported

HR475-TRICARE young adult;HR1302-Gold Star; HR1309-eating disorders; HR1767-languages; HR1836-Guard parity; S943-Parris Island; S781-paid leave; S894-Hire Vets; S156 TRICARE re-enroll; HR333/HR303/S344/HR1282-Concurrent Receipt; S781-Parental Leave; S943-Parris Island Protection; HR2146-Military Family Violence; HR2339- Military Hunger Prevention; HR2214-Final month pay; HR1491-Fair Debt Collection; HR2320- Parental Leave; HR2502- Gender Equity Pay; S1084- Military Spouse Licensing; S1147- Concurrent Receipts; S1572-Military Childcare; HR3102- TRICARE Protection; HR3121- Military Child Care; S1781- Military Nutrition; S1273-Military Spouse Retirement; HR3626- Guard and Reserve Pay Parity; HR3712- Dogs for disease detection; HR3368- Toxic Exposure; HR3512- TRICARE for Reserve; S1967-Childcare Expansion; S1970- Clean Water for Military; S1972- Tricare young adult; S1973-PFAS Toxic Exposure; HR4339- Toxic Exposure; HR4340- Toxic Exposure; HR4379- Burn Pits; S2161- 180day Rule (Skill retaining); HR4861- DoD School Funding; HR4700- Skillbridge Program; HR4702- Military Spouse Tax; HR5061- Mental Health, HR4031- 180 Rule (Retaining Skill); HR4241-PFAS Cleanup; HR4824- Mental Health; HR4882- Recreational Therapy; S2518- Toxic Exposure; S2555- PFAS Cleanup; HR5198 - Casualty Assistance; HR5379 - Pay during lapse in appropriation; HR5403 -PFAS; HR2195 - Protecting Reservist Employment; HR2196- Forced Arbitration; HR5402 - Vetting Privatize Housing; HR5752 - SCRA; HR5255 - Child Impact Aid; HR6227 - Military Children School Meal; HR7041 - Military Records; HR7526 - Credit Monitoring; HR7563- Active Duty Home Ownership; HR7564 - Building More Houses; HR7561 - BAH Restoration;

Client expense: $120,000 · Firm income: Not reported

HR475-TRICARE young adult;HR1302-Gold Star; HR1309-eating disorders; HR1767-languages; HR1836-Guard parity; S943-Parris Island; S781-paid leave; S894-Hire Vets; S156 TRICARE re-enroll; HR333/HR303/S344/HR1282-Concurrent Receipt; S781-Parental Leave; S943-Parris Island Protection; HR2146-Military Family Violence; HR2339- Military Hunger Prevention; HR2214-Final month pay; HR1491-Fair Debt Collection; HR2320- Parental Leave; HR2502- Gender Equity Pay; S1084- Military Spouse Licensing; S1147- Concurrent Receipts; S1572-Military Childcare; HR3102- TRICARE Protection; HR3121- Military Child Care; S1781- Military Nutrition; S1273-Military Spouse Retirement; HR3626- Guard and Reserve Pay Parity; HR3712- Dogs for disease detection; HR3368- Toxic Exposure; HR3512- TRICARE for Reserve; S1967-Childcare Expansion; S1970- Clean Water for Military; S1972- Tricare young adult; S1973-PFAS Toxic Exposure; HR4339- Toxic Exposure; HR4340- Toxic Exposure; HR4379- Burn Pits; S2161- 180day Rule (Skill retaining); HR4861- DoD School Funding; HR4700- Skillbridge Program; HR4702- Military Spouse Tax; HR5061- Mental Health, HR4031- 180 Rule (Retaining Skill); HR4241-PFAS Cleanup; HR4824- Mental Health; HR4882- Recreational Therapy; S2518- Toxic Exposure; S2555- PFAS Cleanup; HR5198 - Casualty Assistance; HR5379 - Pay during lapse in appropriation; HR5403 -PFAS; HR2195 - Protecting Reservist Employment; HR2196- Forced Arbitration; HR5402 - Vetting Privatize Housing; HR5752 - SCRA; HR5255 - Child Impact Aid; HR6227 - Military Children School Meal; HR7041 - Military Records; HR7526 - Credit Monitoring; HR7563- Active Duty Home Ownership; HR7564 - Building More Houses; HR7561 - BAH Restoration;

Client expense: $120,000 · Firm income: Not reported

HR475-TRICARE young adult;HR1302-Gold Star; HR1309-eating disorders; HR1767-languages; HR1836-Guard parity; S943-Parris Island; S781-paid leave; S894-Hire Vets; S156 TRICARE re-enroll; HR333/HR303/S344/HR1282-Concurrent Receipt; S781-Parental Leave; S943-Parris Island Protection; HR2146-Military Family Violence; HR2339- Military Hunger Prevention; HR2214-Final month pay; HR1491-Fair Debt Collection; HR2320- Parental Leave; HR2502- Gender Equity Pay; S1084- Military Spouse Licensing; S1147- Concurrent Receipts; S1572-Military Childcare; HR3102- TRICARE Protection; HR3121- Military Child Care; S1781- Military Nutrition; S1273-Military Spouse Retirement; HR3626- Guard and Reserve Pay Parity; HR3712- Dogs for disease detection; HR3368- Toxic Exposure; HR3512- TRICARE for Reserve; S1967-Childcare Expansion; S1970- Clean Water for Military; S1972- Tricare young adult; S1973-PFAS Toxic Exposure; HR4339- Toxic Exposure; HR4340- Toxic Exposure; HR4379- Burn Pits; S2161- 180day Rule (Skill retaining); HR4861- DoD School Funding; HR4700- Skillbridge Program; HR4702- Military Spouse Tax; HR5061- Mental Health, HR4031- 180 Rule (Retaining Skill); HR4241-PFAS Cleanup; HR4824- Mental Health; HR4882- Recreational Therapy; S2518- Toxic Exposure; S2555- PFAS Cleanup; HR5198 - Casualty Assistance; HR5379 - Pay during lapse in appropriation; HR5403 -PFAS; HR2195 - Protecting Reservist Employment; HR2196- Forced Arbitration; HR5402 - Vetting Privatize Housing; HR5752 - SCRA; HR5255 - Child Impact Aid; HR6227 - Military Children School Meal;

Client expense: $120,000 · Firm income: Not reported

HR475-TRICARE young adult;HR1302-Gold Star; HR1309-eating disorders; HR1767-languages; HR1836-Guard parity; S943-Parris Island; S781-paid leave; S894-Hire Vets; S156 TRICARE re-enroll; HR333/HR303/S344/HR1282-Concurrent Receipt; S781-Parental Leave; S943-Parris Island Protection; HR2146-Military Family Violence; HR2339- Military Hunger Prevention; HR2214-Final month pay; HR1491-Fair Debt Collection; HR2320- Parental Leave; HR2502- Gender Equity Pay; S1084- Military Spouse Licensing; S1147- Concurrent Receipts; S1572-Military Childcare; HR3102- TRICARE Protection; HR3121- Military Child Care; S1781- Military Nutrition; S1273-Military Spouse Retirement; HR3626- Guard and Reserve Pay Parity; HR3712- Dogs for disease detection; HR3368- Toxic Exposure; HR3512- TRICARE for Reserve; S1967-Childcare Expansion; S1970- Clean Water for Military; S1972- Tricare young adult; S1973-PFAS Toxic Exposure; HR4339- Toxic Exposure; HR4340- Toxic Exposure; HR4379- Burn Pits; S2161- 180day Rule (Skill retaining); HR4861- DoD School Funding; HR4700- Skillbridge Program; HR4702- Military Spouse Tax; HR5061- Mental Health, HR4031- 180 Rule (Retaining Skill); HR4241-PFAS Cleanup; HR4824- Mental Health; HR4882- Recreational Therapy; S2518- Toxic Exposure; S2555- PFAS Cleanup; HR5198 - Casualty Assistance; HR5379 - Pay during lapse in appropriation; HR5403 -PFAS; HR2195 - Protecting Reservist Employment; HR2196- Forced Arbitration; HR5402 - Vetting Privatize Housing; HR5752 - SCRA

Client expense: $120,000 · Firm income: Not reported

HR475-TRICARE young adult;HR1302-Gold Star; HR1309-eating disorders; HR1767-languages; HR1836-Guard parity; S943-Parris Island; S781-paid leave; S894-Hire Vets; S156 TRICARE re-enroll; HR333/HR303/S344/HR1282-Concurrent Receipt; S781-Parental Leave; S943-Parris Island Protection; HR2146-Military Family Violence; HR2339- Military Hunger Prevention; HR2214-Final month pay; HR1491-Fair Debt Collection; HR2320- Parental Leave; HR2502- Gender Equity Pay; S1084- Military Spouse Licensing; S1147- Concurrent Receipts; S1572-Military Childcare; HR3102- TRICARE Protection; HR3121- Military Child Care; S1781- Military Nutrition; S1273-Military Spouse Retirement; HR3626- Guard and Reserve Pay Parity; HR3712- Dogs for disease detection; HR3368- Toxic Exposure; HR3512- TRICARE for Reserve; S1967-Childcare Expansion; S1970- Clean Water for Military; S1972- Tricare young adult; S1973-PFAS Toxic Exposure; HR4339- Toxic Exposure; HR4340- Toxic Exposure; HR4379- Burn Pits; S2161- 180day Rule (Skill retaining); HR4861- DoD School Funding; HR4700- Skillbridge Program; HR4702- Military Spouse Tax; HR5061- Mental Health, HR4031- 180 Rule (Retaining Skill); HR4241-PFAS Cleanup; HR4824- Mental Health; HR4882- Recreational Therapy; S2518- Toxic Exposure; S2555- PFAS Cleanup.

Client expense: $120,000 · Firm income: Not reported

HR475-TRICARE young adult;HR1302-Gold Star; HR1309-eating disorders; HR1767-languages; HR1836-Guard parity; S943-Parris Island; S781-paid leave; S894-Hire Vets; S156 TRICARE re-enroll; HR333/HR303/S344/HR1282-Concurrent Receipt; S781-Parental Leave; S943-Parris Island Protection; HR2146-Military Family Violence; HR2339- Military Hunger Prevention; HR2214-Final month pay; HR1491-Fair Debt Collection; HR2320- Parental Leave; HR2502- Gender Equity Pay; S1084- Military Spouse Licensing; S1147- Concurrent Receipts; S1572-Military Childcare; HR3102- TRICARE Protection; HR3121- Military Child Care; S1781- Military Nutrition; S1273-Military Spouse Retirement; HR3626- Guard and Reserve Pay Parity; HR3712- Dogs for disease detection; HR3368- Toxic Exposure; HR3512- TRICARE for Reserve; S1967-Childcare Expansion; S1970- Clean Water for Military; S1972- Tricare young adult; S1973-PFAS Toxic Exposure.

Client expense: $120,000 · Firm income: Not reported